SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-018818
Filing Date
2023-11-13
Accepted
2023-11-13 16:00:43
Documents
61
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q sngx-20230930x10q.htm   iXBRL 10-Q 1736151
2 EX-31.1 sngx-20230930xex31d1.htm EX-31.1 18455
3 EX-31.2 sngx-20230930xex31d2.htm EX-31.2 18513
4 EX-32.1 sngx-20230930xex32d1.htm EX-32.1 8299
5 EX-32.2 sngx-20230930xex32d2.htm EX-32.2 8787
  Complete submission text file 0001558370-23-018818.txt   7353873

Data Files

Seq Description Document Type Size
6 EX-101.SCH sngx-20230930.xsd EX-101.SCH 45153
7 EX-101.CAL sngx-20230930_cal.xml EX-101.CAL 48725
8 EX-101.DEF sngx-20230930_def.xml EX-101.DEF 239054
9 EX-101.LAB sngx-20230930_lab.xml EX-101.LAB 451017
10 EX-101.PRE sngx-20230930_pre.xml EX-101.PRE 354575
55 EXTRACTED XBRL INSTANCE DOCUMENT sngx-20230930x10q_htm.xml XML 1214117
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14778 | Film No.: 231398392
SIC: 2834 Pharmaceutical Preparations